digital gene expression profiling
NanoString Q3 Revenues Rise 7 Percent
NanoString logged $30.6 million in revenues in the third quarter, beating the Wall Street estimate of $28.1 million.
NanoString Q2 Revenues up 21 Percent
Product and service revenues were up 10 percent year over year to $22.4 million compared to $20.4 million in the year-ago quarter.
NanoString, Mayo Clinic to Develop Novel Assays in High-Risk Breast Cancer and Leukemia
The partners will use the GeoMx Digital Spatial Profiler to identify new biomarkers in high-risk breast cancer and the nCounter to evaluate leukemia fusion testing.
NanoString Revenues Climb 18 Percent in Q1
The company reported total revenues of $27.7 million, with growth in its consumables business but a drop in instrument revenues from the prior year's first quarter.
NanoString Q4 Revenues Fall 15 Percent, Beat Wall Street Expectations
Though the firm saw lower overall revenue, it increased its fourth quarter and full-year product and services revenue by 12 percent and 16 percent respectively.